145 related articles for article (PubMed ID: 21859840)
21. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities.
Alappat EC; Feig C; Boyerinas B; Volkland J; Samuels M; Murmann AE; Thorburn A; Kidd VJ; Slaughter CA; Osborn SL; Winoto A; Tang WJ; Peter ME
Mol Cell; 2005 Aug; 19(3):321-32. PubMed ID: 16061179
[TBL] [Abstract][Full Text] [Related]
22. Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer.
Bhojani MS; Chen G; Ross BD; Beer DG; Rehemtulla A
Cell Cycle; 2005 Nov; 4(11):1478-81. PubMed ID: 16258269
[TBL] [Abstract][Full Text] [Related]
23. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
24. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD.
Jang MS; Lee SJ; Kim CJ; Lee CW; Kim E
Oncogene; 2011 Jan; 30(4):471-81. PubMed ID: 20890306
[TBL] [Abstract][Full Text] [Related]
26. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
27. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
[TBL] [Abstract][Full Text] [Related]
28. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
Ikner A; Ashkenazi A
J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
[TBL] [Abstract][Full Text] [Related]
29. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
Mohammad RM; Banerjee S; Li Y; Aboukameel A; Kucuk O; Sarkar FH
Cancer; 2006 Mar; 106(6):1260-8. PubMed ID: 16475211
[TBL] [Abstract][Full Text] [Related]
31. The IL-8 production by Streptococcal pyrogenic exotoxin B.
Chang CW; Wu SY; Chuang WJ; Lin YS; Wu JJ; Liu CC; Tsai PJ; Lin MT
Exp Biol Med (Maywood); 2009 Nov; 234(11):1316-26. PubMed ID: 19855073
[TBL] [Abstract][Full Text] [Related]
32. The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Matsuyoshi S; Konishi N
Mol Carcinog; 2004 Jan; 39(1):1-9. PubMed ID: 14694442
[TBL] [Abstract][Full Text] [Related]
33. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
34. Effect of infliximab combined with methylprednisolone on expressions of NF-κB, TRADD, and FADD in rat acute spinal cord injury.
Chengke L; Weiwei L; Xiyang W; Ping W; Xiaoyang P; Zhengquan X; Hao Z; Penghui Z; Wei P
Spine (Phila Pa 1976); 2013 Jun; 38(14):E861-9. PubMed ID: 23574812
[TBL] [Abstract][Full Text] [Related]
35. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
Harper N; Hughes M; MacFarlane M; Cohen GM
J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
[TBL] [Abstract][Full Text] [Related]
36. Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death.
Hsu WH; Zhao X; Zhu J; Kim IK; Rao G; McCutcheon J; Hsu ST; Teicher B; Kallakury B; Dowlati A; Zhang YW; Giaccone G
J Thorac Oncol; 2019 Jun; 14(6):1032-1045. PubMed ID: 30771522
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.
Gao ZW; Zhang DL; Guo CB
Curr Cancer Drug Targets; 2010 Nov; 10(7):705-15. PubMed ID: 20578985
[TBL] [Abstract][Full Text] [Related]
38. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
[TBL] [Abstract][Full Text] [Related]
39. Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma.
Hassan MS; Williams F; Awasthi N; Schwarz MA; Schwarz RE; Li J; von Holzen U
Sci Rep; 2019 Nov; 9(1):17608. PubMed ID: 31772236
[TBL] [Abstract][Full Text] [Related]
40. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
